Clinical trials for medicines: authorisation assessment performance
Data on the time taken by the MHRA to assess clinical trial applications and substantial amendments.
Read the news from Medicines and Healthcare products Regulatory Agency updated on 23 August 2021 here
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (9 mars 2022). Clinical trials for medicines: authorisation assessment performance. ELSIBI. Consulté le 19 janvier 2026 à l’adresse https://doi.org/10.58079/o5tx





